U.S. Capital Wealth Advisors’s Colgate-Palmolive CL Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$454K	Buy	5,326 +705	+15%	+$62.8K	0.01%	697
2025 Q4	$365K	Buy	4,621 +2,036	+79%	+$160K	0.01%	742
2025 Q3	$207K	Buy	2,585 +292	+13%	+$24.9K	0.01%	888
2025 Q2	$208K	Buy	2,293 +105	+5%	+$9.59K	0.01%	826
2025 Q1	$205K	Buy	+2,188	New	+$196K	0.01%	795
2023 Q1	–	Sell	-1,703	Closed	-$134K	–	794
2022 Q4	$134K	Buy	+1,703	New	+$128K	0.01%	683
2022 Q1	–	Sell	-64,539	Closed	-$5.51M	–	716
2021 Q4	$5.51M	Sell	64,539 -6	-0%	-$469	0.22%	105
2021 Q3	$4.88M	Buy	+64,545	New	+$5.13M	0.21%	119

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

U.S. Capital Wealth Advisors's CL Position: Q1 2026 in Review

U.S. Capital Wealth Advisors increased its Colgate-Palmolive (CL) stake by 15% in Q1 2026, buying an estimated $62.8K and bringing the position to 5,326 shares worth $454K. The position accounts for 0.01% of the portfolio, ranked #697.

U.S. Capital Wealth Advisors first reported a position in CL in Q3 2021 and has held it in 8 quarters since. The position peaked at $5.51M in Q4 2021. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

U.S. Capital Wealth Advisors held 5,326 shares of Colgate-Palmolive worth $454K as of Q1 2026.
U.S. Capital Wealth Advisors bought 705 Colgate-Palmolive shares in Q1 2026, an estimated $62.8K.
Colgate-Palmolive made up 0.01% of U.S. Capital Wealth Advisors's portfolio in Q1 2026, its #697 holding.
U.S. Capital Wealth Advisors first reported a position in Colgate-Palmolive in Q3 2021 and has held it in 8 quarters since.
U.S. Capital Wealth Advisors's Colgate-Palmolive position peaked at $5.51M in Q4 2021.
1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.